Juxtaglomerular Cells, located near the glomerulus in the kidneys, are essential components of the renal apparatus, contributing to blood pressure regulation and the renin-angiotensin-aldosterone system. These specialized cells exist in two distinct types: macula densa cells, located in the distal tubule, and granular cells (also known as juxtaglomerular cells proper), found in the afferent arteriole. Macula densa cells sense changes in sodium concentration in the filtrate, providing feedback to granular cells. Granular cells, in response to this feedback or low blood pressure, release renin into the bloodstream. Renin initiates a cascade leading to the production of angiotensin II, a potent vasoconstrictor that raises blood pressure. Additionally, angiotensin II stimulates the release of aldosterone, promoting sodium and water retention, further influencing blood volume and pressure. Juxtaglomerular cells play a crucial role in the regulation of glomerular filtration rate and systemic blood pressure. Dysregulation of these cells can contribute to conditions such as hypertension or hypotension. Understanding the function of juxtaglomerular cells is essential for comprehending renal physiology and holds implications for the diagnosis and management of cardiovascular and renal disorders.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy